✦ LIBER ✦

Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS)

✍ Scribed by Felicita Andreotti; Luciano Agati; Elena Conti; Eleonora Santucci; Teresa Rio; Federica Tarantino; Luigi Natale; Daniele Berardi; Antonella Mattatelli; Beatrice Musumeci; Lorenzo Bonomo; Massimo Volpe; Filippo Crea; Camillo Autore

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 246 KB
Volume: 28
Category: Article
ISSN: 0929-5305
DOI: 10.1007/s11239-009-0363-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, placebo-controlled study of

Randomized, placebo-controlled study of Lamifiban with thrombolytic therapy for the treatment of acute myocardial infarction: Rationale and design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) study

✍ David J. Moliterno; Robert A. Harrington; Robert M. Califf; Hans J. Rapold; Eric 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 583 KB

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Rationale and Design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) Study

✍ Ik-Kyung Jang; Veronica Pettigrew; Michael H. Picard; Peter R. Kowey; Valentin D 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 219 KB